Potentiation of anti-cancer effect by intravenous administration of vesiculated α-tocopheryl hemisuccinate on mouse melanoma in vivo
- 8 January 2003
- journal article
- research article
- Published by Elsevier in Cancer Letters
- Vol. 192 (1), 19-24
- https://doi.org/10.1016/s0304-3835(02)00683-3
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- High cytotoxicity of α-tocopheryl hemisuccinate to cancer cells is due to failure of their antioxidative defense systemsCancer Letters, 2002
- Enhancement by α-tocopheryl hemisuccinate of nitric oxide production induced by lypopolysaccharide and interferon-γ through the upregulation of protein kinase C in rat vascular smooth muscle cellsEuropean Journal of Biochemistry, 2002
- Superoxide is responsible for apoptosis in rat vascular smooth muscle cells induced by α-tocopheryl hemisuccinateBiochimica et Biophysica Acta (BBA) - General Subjects, 2001
- Vitamin E analogues as inducers of apoptosis: implications for their potential antineoplastic roleRedox Report, 2001
- Vitamin E Succinate Promotes Breast Cancer Tumor DormancyJournal of Surgical Research, 2000
- c-Jun involvement in vitamin E succinate induced apoptosis of reticuloendotheliosis virus transformed avian lymphoid cellsOncogene, 1997
- LiposomenDrugs, 1997
- pH-Sensitive liposomes composed of tocopherol hemisuccinate and of phosphatidylethanolamine including tocopherol hemisuccinateBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1994
- Protection against carbon tetrachloride-induced hepatotoxicity by pretreating rats with the hemisuccinate esters of tocopherol and cholesterol.Environmental Health Perspectives, 1993
- Inhibition of NF-κB Activation by Vitamin E DerivativesBiochemical and Biophysical Research Communications, 1993